Cited by 271MicroRNA in disease regulationAngiogenesis and VEGF in CancerNitric Oxide and Endothelin Effects

The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.

MicroRNA‐320 EXPRESSION IN MYOCARDIAL MICROVASCULAR ENDOTHELIAL CELLS AND ITS RELATIONSHIP WITH INSULIN‐LIKE GROWTH FACTOR‐1 IN TYPE 2 DIABETIC RATS

Wang, XH, Qian, RZ, Zhang, W, Chen, SF, Jin, HM, Hu, RM·2009·Clinical and Experimental Pharmacology and Physiology

DOI 10.1111/j.1440-1681.2008.05057.x

Open this paper in CoChat — free account

Abstract

SUMMARY: The aim of the present study was to determine the role of myocardial microvascular endothelial cells (MMVEC) in impaired angiogenesis of type 2 diabetic Goto‐Kakizaki (GK) rats. A microRNA (miRNA) microarray was used to assess miRNA expression in MMVEC from GK and Wistar rats. Upregulation of miRNA‐320 was observed in MMVEC from GK rats using real‐time reverse transcription–polymerase chain reaction (RT‐PCR). So far, nine miRNAs have been reported to target angiogenic factors and/or receptors, including kinase insert domain containing receptor (Flk‐1), insulin‐like growth factor 1 (IGF‐1) and insulin‐like growth factor 1 receptor (IGF‐1R). The predicted genes targeted by miR‐320 include Flk‐1, IGF‐1 and IGF‐1R. Western blot analysis and RT‐PCR were used to analyse the protein and mRNA expression, respectively, of the putative genes IGF‐1 and IGF‐1R. The expression of IGF‐1 and IGF‐1R proteins decreased significantly in diabetic MMVEC. However, the expression of IGF‐1 mRNA increased rather than decreased. The mRNA expression of IGF‐1R did not differ significantly between diabetic and control MMVEC. Transfection of an miR‐320 inhibitor into MMVEC from GK rats confirmed that miR‐320 impaired angiogenesis. The proliferation and migration of diabetic MMVEC improved after transfection of the miR‐320 inhibitor. In addition, the miR‐320 inhibitor significantly increased the expression of IGF‐1 protein, but had no effect on the expression of IGF‐1R. Eleven miRNAs were upregulated in MMVEC from GK rats compared with those in Wistar rats: let‐7e, miR‐129, miR‐291‐5p, miR‐320, miR‐327, mir‐333, miR‐363–5p, miR‐370, miR‐494, miR‐503 and miR‐664. The results indicate that upregulation of miR‐320 in MMVEC from GK rats may be responsible for the inconsistency between the expression of IGF‐1 protein and mRNA and therefore related to impaired angiogenesis in diabetes. Transfection of an miR‐320 inhibitor may be a therapeutic approach for the treatment of impaired angiogenesis in diabetes.

Integrity signals

Registry

Crossref · 10.1111/j.1440-1681.2008.05057.x

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Untitled work
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993) · Cell · doi:10.1016/0092-8674(93)90529-y · Cited by 12,948
Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
Prediction of Mammalian MicroRNA Targets
Lewis, B. P., Shih, I.-H., Jones-Rhoades, M. W., Bartel, D. P., & Burge, C. B. (2003) · Cell · doi:10.1016/s0092-8674(03)01018-3 · Cited by 5,199
The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans
Reinhart, B. J., Slack, F. J., Basson, M., Pasquinelli, A. E., Bettinger, J. C., Rougvie, A. E., Horvitz, H. R., & Ruvkun, G. (2000) · Nature · doi:10.1038/35002607 · Cited by 4,989
Combinatorial microRNA target predictions
Krek, A., Grün, D., Poy, M. N., Wolf, R., Rosenberg, L., Epstein, E. J., MacMenamin, P., da Piedade, I., Gunsalus, K. C., Stoffel, M., et al. (2005) · Nature Genetics · doi:10.1038/ng1536 · Cited by 4,603
MicroRNA Gene Expression Deregulation in Human Breast Cancer
Iorio, M. V., Ferracin, M., Liu, C.-G., Veronese, A., Spizzo, R., Sabbioni, S., Magri, E., Pedriali, M., Fabbri, M., Campiglio, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1783 · Cited by 4,053
Human MicroRNA Targets
John, B., Enright, A. J., Aravin, A., Tuschl, T., Sander, C., & Marks, D. S. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020363 · Cited by 3,796
MicroRNAs Modulate Hematopoietic Lineage Differentiation
Chen, C.-Z., Li, L., Lodish, H. F., & Bartel, D. P. (2004) · Science · doi:10.1126/science.1091903 · Cited by 3,257
The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation
Chen, J., Mandel, E. M., Thomson, J. M., Wu, Q., Callis, T. E., Hammond, S. M., Conlon, F. L., & Wang, D.-Z. (2005) · Nature Genetics · doi:10.1038/ng1725 · Cited by 2,807

Show all 38 references

Research works printed but not linked: 1

Ning YX, 2005, Study on the cytological characteristics of rat myocardium microvascular endothelial cells in culture of primary passage by microarray, Chin. J. Pathophysiol, 21, 2295

Sorted by citations

Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I
Paneni, F., Beckman, J. A., Creager, M. A., & Cosentino, F. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht149 · Cited by 1,455
Extracellular miRNAs: From Biomarkers to Mediators of Physiology and Disease
Mori, M. A., Ludwig, R. G., García-Martín, R., Brandão, B. B., & Kahn, C. R. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.07.011 · Cited by 990
Endothelial Cell Metabolism
Eelen, G., de Zeeuw, P., Treps, L., Harjes, U., Wong, B. W., & Carmeliet, P. (2017) · Physiological Reviews · doi:10.1152/physrev.00001.2017 · Cited by 614
AngiomiRs—Key regulators of angiogenesis
Wang, S., & Olson, E. N. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.04.002 · Cited by 456
MicroRNA 144 Impairs Insulin Signaling by Inhibiting the Expression of Insulin Receptor Substrate 1 in Type 2 Diabetes Mellitus
Karolina, D. S., Armugam, A., Subramaniam, T., Wong, M. T. K., Lim, S. C., Sum, C. F., & Jeyaseelan, K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022839 · Cited by 445
Interplay between miRNAs and human diseases
Paul, P., Chakraborty, A., Sarkar, D., Langthasa, M., Rahman, M., Bari, M., Singha, R. S., Malakar, A. K., & Chakraborty, S. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.25854 · Cited by 420
Cardiomyocytes mediate anti-angiogenesis in type 2 diabetic rats through the exosomal transfer of miR-320 into endothelial cells
Wang, X., Huang, W. C., Liu, G., Cai, W., Millard, R. W., Wang, Y., Chang, J., Peng, T., & Fan, G. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.05.001 · Cited by 413
Self-citation
Deregulation of microRNA-503 Contributes to Diabetes Mellitus–Induced Impairment of Endothelial Function and Reparative Angiogenesis After Limb Ischemia
Caporali, A., Meloni, M., Völlenkle, C., Bonci, D., Sala-Newby, G. B., Addis, R., Spinetti, G., Losa, S., Masson, R., Baker, A. H., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.952325 · Cited by 397
Expression Profile of MicroRNAs in Young Stroke Patients
Tan, K. S., Armugam, A., Sepramaniam, S., Lim, K. Y., Karolina, D. S., Wang, C. W., & Jeyaseelan, K. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007689 · Cited by 397
Bovine milk contains microRNA and messenger RNA that are stable under degradative conditions
Izumi, H., Kosaka, N., Shimizu, T., Sekine, K., Ochiya, T., & Takase, M. (2012) · Journal of Dairy Science · doi:10.3168/jds.2012-5489 · Cited by 385
Identification of Therapeutic Covariant MicroRNA Clusters in Hypoxia-Treated Cardiac Progenitor Cell Exosomes Using Systems Biology
Gray, W. D., French, K. M., Ghosh-Choudhary, S. K., Maxwell, J. T., Brown, M. E., Platt, M. O., Searles, C. D., & Davis, M. E. (2014) · Circulation Research · doi:10.1161/circresaha.116.304360 · Cited by 382
Signature microRNA Expression Profile of Essential Hypertension and Its Novel Link to Human Cytomegalovirus Infection
Li, S., Zhu, J., Zhang, W., Chen, Y., Zhang, K., Popescu, L. M., Ma, X., Lau, W. B., Rong, R., Yu, X., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.012237 · Cited by 334
Self-citation
MicroRNAs and cardiac pathology
Latronico, M. V. G., & Condorelli, G. (2009) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.56 · Cited by 320
MicroRNA-494 Targeting Both Proapoptotic and Antiapoptotic Proteins Protects Against Ischemia/Reperfusion-Induced Cardiac Injury
Wang, X., Zhang, X., Ren, X., Chen, J., Liu, H., Yang, J., Medvedovic, M., Hu, Z., & Fan, G. (2010) · Circulation · doi:10.1161/circulationaha.110.964684 · Cited by 297
Self-citation
Diabetes Complications: The MicroRNA Perspective
Kantharidis, P., Wang, B., Carew, R. M., & Lan, H. Y. (2011) · Diabetes · doi:10.2337/db11-0082 · Cited by 292
Role of microRNAs in diabetes and its cardiovascular complications
Shantikumar, S., Caporali, A., & Emanueli, C. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvr300 · Cited by 263
Myocardial AKT: The Omnipresent Nexus
Sussman, M. A., Völkers, M., Fischer, K. M., Bailey, B., Cottage, C. T., Din, S., Gude, N. A., Avitabile, D., Alvarez, R., Sundararaman, B., et al. (2011) · Physiological Reviews · doi:10.1152/physrev.00024.2010 · Cited by 237
Cellular and molecular mechanisms of endothelial dysfunction in diabetes
Roberts, A., & Porter, K. E. (2013) · Diabetes and Vascular Disease Research · doi:10.1177/1479164113500680 · Cited by 234
CHANGES IN microRNA (miR) PROFILE AND EFFECTS OF miR‐320 IN INSULIN‐RESISTANT 3T3‐L1 ADIPOCYTES
Ling, H., Ou, H., Feng, S., Zhang, X., Tuo, Q., Chen, L., Zhu, B., Gao, Z., Tang, C., Yin, W., et al. (2009) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2009.05207.x · Cited by 221
MicroRNAs in β-Cell Biology, Insulin Resistance, Diabetes and Its Complications
Fernández-Valverde, S. L., Taft, R. J., & Mattick, J. S. (2011) · Diabetes · doi:10.2337/db11-0171 · Cited by 215
miR-146a–Mediated Extracellular Matrix Protein Production in Chronic Diabetes Complications
Feng, B., Chen, S., Mcarthur, K., Wu, Y., Sen, S., Ding, Q., Feldman, R. D., & Chakrabarti, S. (2011) · Diabetes · doi:10.2337/db11-0478 · Cited by 196
Self-citation
Antioxidant Therapeutic Strategies for Cardiovascular Conditions Associated with Oxidative Stress
Farías, J. G., Molina, V. M., Carrasco, R. A., Zepeda, A. B., Figueroa, E., Letelier, P. J., & Castillo, R. L. (2017) · Nutrients · doi:10.3390/nu9090966 · Cited by 195
miRNAs as Modulators of AngiogenesisPreprint
Landskroner-Eiger, S., Moneke, I., & Sessa, W. C. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006643 · Cited by 190
Emerging Roles for MicroRNAs in Diabetic Microvascular Disease: Novel Targets for Therapy
Zhang, Y., Sun, X., Icli, B., & Feinberg, M. W. (2017) · Endocrine Reviews · doi:10.1210/er.2016-1122 · Cited by 191
MicroRNAs in Diabetes: Tiny Players in Big Disease
Pandey, A. K., Agarwal, P., Kaur, K., & Datta, M. (2009) · Cellular Physiology and Biochemistry · doi:10.1159/000218169 · Cited by 183
The therapeutic and diagnostic role of exosomes in cardiovascular diseases
Zamani, P., Fereydouni, N., Butler, A. E., Navashenaq, J. G., & Sahebkar, A. (2018) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2018.10.010 · Cited by 184
Exosomes Function in Pro- and Anti-Angiogenesis
Ribeiro, M. F., Zhu, H., Millard, R. W., & Fan, G. (2013) · Current Angiogenesis · doi:10.2174/22115528113020020001 · Cited by 180
microRNA: Emerging therapeutic targets in acute ischemic diseases
Fasanaro, P., Greco, S., Ivan, M., Capogrossi, M. C., & Martelli, F. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.10.003 · Cited by 175
Role of microRNAs in the reperfused myocardium towards post-infarct remodelling
Zhu, H., & Fan, G. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr291 · Cited by 170
Cardiac Extracellular Vesicles in Normal and Infarcted Heart
Chistiakov, D. A., Orekhov, A. N., & Bobryshev, Y. V. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17010063 · Cited by 166
Downregulation of Endothelial MicroRNA-200b Supports Cutaneous Wound Angiogenesis By Desilencing GATA Binding Protein 2 and Vascular Endothelial Growth Factor Receptor 2
Chan, Y. C., Roy, S., Khanna, S., & Sen, C. K. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.248583 · Cited by 154
Angiogenesis-regulating microRNAs and Ischemic Stroke
Yin, K., Hamblin, M., & Chen, Y. (2015) · Current Vascular Pharmacology · doi:10.2174/15701611113119990016 · Cited by 153
miR-126 contributes to Parkinson's disease by dysregulating the insulin-like growth factor/phosphoinositide 3-kinase signaling
Kim, W., Lee, Y., McKenna, N. D., Yi, M., Šimunović, F., Wang, Y., Kong, B., Rooney, R. J., Seo, H., Stephens, R. M., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.01.021 · Cited by 151
Diabetes Mellitus and Ischemic Diseases
Howangyin, K. Y., & Silvestre, J. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.303090 · Cited by 144
MicroRNA-494 Reduces ATF3 Expression and Promotes AKI
Lan, Y., Chen, H.-H., Lai, P., Cheng, C., Huang, Y.-T., Lee, Y., Chen, T., & Lin, H. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012050438 · Cited by 138
The Vasculature in Prediabetes
Wasserman, D. H., Wang, T. J., & Brown, N. J. (2018) · Circulation Research · doi:10.1161/circresaha.118.311912 · Cited by 137
miR-320 regulates tumor angiogenesis driven by vascular endothelial cells in oral cancer by silencing neuropilin 1
Wu, Y.-Y., Chen, Y., Jao, Y.-C., Hsieh, I., Chang, K., & Hong, T.-M. (2013) · Angiogenesis · doi:10.1007/s10456-013-9394-1 · Cited by 137
MicroRNAs in skin and wound healing
Banerjee, J., Chan, Y. C., & Sen, C. K. (2010) · Physiological Genomics · doi:10.1152/physiolgenomics.00157.2010 · Cited by 139
Relationship Between Downregulation of miRNAs and Increase of Oxidative Stress in the Development of Diabetic Cardiac Dysfunction: Junctin as a Target Protein of miR-1
Yildirim, S. S., Akman, D., Catalucci, D., & Turan, B. (2013) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-013-9672-y · Cited by 129
Endothelial MicroRNAs and Atherosclerosis
Sun, X., Belkin, N., & Feinberg, M. W. (2013) · Current Atherosclerosis Reports · doi:10.1007/s11883-013-0372-2 · Cited by 134
MicroRNAs: potential mediators and biomarkers of diabetic complications
Kato, M. V., Castro, N., & Natarajan, R. D. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.06.009 · Cited by 121
MicroRNA as Therapeutic Targets for Chronic Wound Healing
Mulholland, E. J., Dunne, N., & McCarthy, H. O. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.06.003 · Cited by 125
MicroRNAs as biomarkers of diabetic retinopathy and disease progression
Peplow, P., & Martinez, B. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.259602 · Cited by 115
microRNA and aging: A novel modulator in regulating the aging network
Chen, L.-H., Chiou, G., Chen, Y., Li, H.-Y., & Chiou, S. (2010) · Ageing Research Reviews · doi:10.1016/j.arr.2010.08.002 · Cited by 117
MicroRNAs and Type 2 Diabetes/Obesity
Dehwah, M. A. S., Xu, A., & Huang, Q. (2011) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2011.11.007 · Cited by 114
microRNA-320a inhibits tumor invasion by targeting neuropilinï¿½1 and is associated with liver metastasis in colorectal cancer
Liu, Y. (2011) · Oncology Reports · doi:10.3892/or.2011.1561 · Cited by 109
Novel modulators of senescence, aging, and longevity: Small non-coding RNAs enter the stage
Grillari, J., & Grillari‐Voglauer, R. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.01.007 · Cited by 108
MicroRNA in Aging: From Discovery to Biology
Jung, H. J., & Suh, Y. (2012) · Current Genomics · doi:10.2174/138920212803251436 · Cited by 109
Epigenetic Modifications and Diabetic Retinopathy
Kowluru, R. A., dos Santos, J. M., & Mishra, M. (2013) · BioMed Research International · doi:10.1155/2013/635284 · Cited by 110
MiR‐320a contributes to atherogenesis by augmenting multiple risk factors and down‐regulating SRF
Chen, C., Wang, Y., Yang, S., Li, H., Zhao, G., Wang, F. Y., Yang, L., & Wang, D. W. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12483 · Cited by 103
Role of microRNA in diabetic cardiomyopathy: From mechanism to intervention
Guo, R., & Nair, S. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.03.013 · Cited by 103
MiRNA inhibition in tissue engineering and regenerative medicine
Beavers, K. R., Nelson, C. E., & Duvall, C. L. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.12.006 · Cited by 101
MicroRNAs and Diabetic Complications
Natarajan, R. D., Putta, S., & Kato, M. V. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9368-5 · Cited by 100
Pathophysiological Fundamentals of Diabetic Cardiomyopathy
Hu, X., Bai, T., Xu, Z., Liu, Q., Zheng, Y., & Cai, L. (2017) · Comprehensive physiology · doi:10.1002/cphy.c160021 · Cited by 103
Alterations in microRNA expression profile in HCV-infected hepatoma cells: Involvement of miR-491 in regulation of HCV replication via the PI3 kinase/Akt pathway
Ishida, H., Tatsumi, T., Hosui, A., Nawa, T., Kodama, T., Shimizu, S., Hikita, H., Hiramatsu, N., Kanto, T., Hayashi, N., et al. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.07.049 · Cited by 95
Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease
Montag, J., Hitt, R., Opitz, L., Schulz‐Schaeffer, W., Hunsmann, G., & Motzkus, D. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-36 · Cited by 94
miR-320 Regulates Glucose-Induced Gene Expression in Diabetes
Feng, B., & Chakrabarti, S. (2012) · ISRN Endocrinology · doi:10.5402/2012/549875 · Cited by 93
Solexa Sequencing Identification of Conserved and Novel microRNAs in Backfat of Large White and Chinese Meishan Pigs
Chen, C., Deng, B., Qiao, M., Zheng, R., Chai, J., Ding, Y., Peng, J., & Jiang, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031426 · Cited by 91
Bone marrow mesenchymal stem cells for post‐myocardial infarction cardiac repair: microRNAs as novel regulators
Wen, Z., Zheng, S., Zhou, C., Yuan, W., Wang, J., & Wang, T. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01471.x · Cited by 91
MicroRNA as a Therapeutic Target in Cardiac Remodeling
Chen, C., Ponnusamy, M., Liu, C., Gao, J., Wang, K., & Li, P. (2017) · BioMed Research International · doi:10.1155/2017/1278436 · Cited by 91
Non‐coding RNA involvement in the pathogenesis of diabetic cardiomyopathy
Zhang, W., Xu, W., Feng, Y. Y., & Zhou, X. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14510 · Cited by 86
Self-citation
MicroRNAs as pharmacological targets in diabetes
Mao, Y., Mohan, R., Zhang, S., & Tang, X. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.06.005 · Cited by 87
MicroRNA-503 and the Extended MicroRNA-16 Family in Angiogenesis
Caporali, A., & Emanueli, C. (2011) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2012.05.003 · Cited by 85
MicroRNAs and Cardiovascular Diseases
Nishiguchi, T., Imanishi, T., & Akasaka, T. (2015) · BioMed Research International · doi:10.1155/2015/682857 · Cited by 83
Comparisons of microRNA expression profiles in vitreous humor between eyes with macular hole and eyes with proliferative diabetic retinopathy
Hirota, K., Keino, H., Inoue, M., Ishida, H., & Hirakata, A. (2014) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-014-2692-5 · Cited by 84
Tissue-Specific Molecular Biomarker Signatures of Type 2 Diabetes: An Integrative Analysis of Transcriptomics and Protein–Protein Interaction Data
Turanlı, B., Karagoz, K., Sevimoğlu, T., Kılıç, E., Göv, E., & Arğa, K. Y. (2015) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2015.0088 · Cited by 87
Micro RNA ‐503 promotes angiotensin II‐induced cardiac fibrosis by targeting Apelin‐13
Zhou, Y., Deng, L., Zhao, D., Chen, L., Yao, Z., Guo, X., Liu, X., Lv, L., Leng, B., Xu, W., et al. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12754 · Cited by 78
Identification of microRNAs with a role in glucose stimulated insulin secretion by expression profiling of MIN6 cells
Hennessy, E., CLYNES, M. M., Jeppesen, P. B., & O’Driscoll, L. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.04.116 · Cited by 76
The Role of MicroRNAs in the Pathogenesis of Diabetic Nephropathy
Tang, J., Yao, D., Yan, H., Chen, X., Wang, L., & Zhan, H. (2019) · International Journal of Endocrinology · doi:10.1155/2019/8719060 · Cited by 75
Noncoding RNAs in diabetes vascular complications
Beltrami, C., Angelini, T. G., & Emanueli, C. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.12.014 · Cited by 75
Roles of microRNAs in atherosclerosis and restenosis
Chen, L. J., Lim, S. H., Yeh, Y. T., Lien, S.-C., & Chiu, J. (2012) · Journal of Biomedical Science · doi:10.1186/1423-0127-19-79 · Cited by 73
Down-regulation of microRNA-320 suppresses cardiomyocyte apoptosis and protects against myocardial ischemia and reperfusion injury by targeting IGF-1
Song, C., Liu, B., Diao, H., Shi, Y., Zhang, J., Li, Y., Liu, N., Yu, Y.-P., Wang, G., Wang, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9240 · Cited by 72
Retracted
MicroRNA-98 induces an Alzheimer’s disease-like disturbance by targeting insulin-like growth factor 1
Hu, Y., Wang, X., Li, L., Du, Y., Ye, H.-T., & Li, C. (2013) · Neuroscience Bulletin · doi:10.1007/s12264-013-1348-5 · Cited by 72
Self-citation
Molecular mechanism of diabetic cardiomyopathy and modulation of microRNA function by synthetic oligonucleotides
Ghosh, N., & Katare, R. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0684-1 · Cited by 71
MicroRNAs in the tumor endothelium: Novel controls on the angioregulatory switchboard
Heusschen, R., van Gink, M., Griffioen, A. W., & Thijssen, V. L. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.09.005 · Cited by 71
The role of miR-320 in glucose and lipid metabolism disorder-associated diseases
Du, H., Zhao, Y., Yin, Z., Wang, D. W., & Chen, C. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.53419 · Cited by 68
Role and therapeutic potential of microRNAs in diabetes
Kolfschoten, I., Roggli, E., Nesca, V., & Regazzi, R. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01118.x · Cited by 71
Minireview: Posttranscriptional Regulation of the Insulin and Insulin-Like Growth Factor Systems
Lee, E. K., & Gorospe, M. (2009) · Endocrinology · doi:10.1210/en.2009-1123 · Cited by 66
MicroRNAs: a new ray of hope for diabetes mellitus
Kumar, M., Nath, S., Prasad, H. K., Sharma, G., & Li, Y. (2012) · Protein & Cell · doi:10.1007/s13238-012-2055-0 · Cited by 66
MicroRNAs and vascular (dys)function
Hartmann, D., & Thum, T. (2011) · Vascular Pharmacology · doi:10.1016/j.vph.2011.07.005 · Cited by 67
Diabetic nephropathy and endothelial dysfunction: Current and future therapies, and emerging of vascular imaging for preclinical renal-kinetic study
Leung, W. K. C., Gao, L., Siu, P. M., & Lai, C. W. K. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.10.015 · Cited by 65
Effects of down-regulation of microRNA-23a on TNF-α-induced endothelial cell apoptosis through caspase-dependent pathways
Ruan, W., Xu, J., Li, S.-B., Yuan, L., & Dai, R.-P. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr290 · Cited by 64
MiR-320a induces diabetic nephropathy via inhibiting MafB
He, M., Wang, J., Yin, Z., Zhao, Y., Hou, H., Fan, J., Li, H., Zheng, W., Tang, J., Wang, Y., et al. (2019) · Aging · doi:10.18632/aging.101962 · Cited by 62
The role of miRNAs in cardiovascular disease risk factors
Buie, J. N. J., Goodwin, A. J., IV, Cook, J. A., Halushka, P. V., & Fan, H. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.09.067 · Cited by 63
MicroRNA, Proteins, and Metabolites as Novel Biomarkers for Prediabetes, Diabetes, and Related Complications
Vaishya, S., Sarwade, R. D., & Seshadri, V. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00180 · Cited by 67
Noncoding RNA s as therapeutic targets in atherosclerosis with diabetes mellitus
Tang, N., Jiang, S., Yang, Y., Liu, S., Ponnusamy, M., Xin, H., & Yu, T. (2018) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12436 · Cited by 63
Up-Regulation of MicroRNA-190b Plays a Role for Decreased IGF-1 That Induces Insulin Resistance in Human Hepatocellular Carcinoma
Hung, T., Ho, C., Liu, Y., Lee, J.-L., Liao, Y.-R., Wu, Y., Ho, M., Chen, C., Lai, H., & Lee, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089446 · Cited by 60
Oxidative-stress-induced epigenetic changes in chronic diabetic complications
Feng, B., Ruiz, M. A., & Chakrabarti, S. (2012) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2012-0251 · Cited by 59
MicroRNAs in CNS injury: Potential roles and therapeutic implications
Madathil, S. K., Nelson, P. T., Saatman, K. E., & Wilfred, B. R. (2010) · BioEssays · doi:10.1002/bies.201000069 · Cited by 58
Deciphering Non-coding RNAs in Cardiovascular Health and Disease
Das, A., Samidurai, A., & Salloum, F. N. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00073 · Cited by 56
MiR-126 Regulates Growth Factor Activities and Vulnerability to Toxic Insult in Neurons
Kim, W., Noh, H., Lee, Y., Jeon, J., Shanmugavadivu, A., McPhie, D. L., Kim, K., Cohen, B. M., Seo, H., & Sonntag, K. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8989-x · Cited by 56
Inhibition of microRNA‐327 ameliorates ischemia/reperfusion injury‐induced cardiomyocytes apoptosis through targeting apoptosis repressor with caspase recruitment domain
Li, Q., Yang, J., Zhang, J., Liu, X., Yang, C., Fan, Z., Wang, H., Yang, Y., Zheng, T., & Yang, J. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29270 · Cited by 56
Glioma angiogenesis
Würdinger, T., & Tannous, B. A. (2009) · Cell Adhesion & Migration · doi:10.4161/cam.3.2.7910 · Cited by 54
Circulating microRNA profiles in different arterial territories of stable atherosclerotic disease: a systematic review.
Pereira‐da‐Silva, T., Cruz, M. C., Carrusca, C., Ferreira, F., Napoleão, P., & Carmo, M. M. (2018) · Europe PMC (PubMed Central) · Cited by 53
Emerging Role of mTOR Signaling‐Related miRNAs in Cardiovascular Diseases
Samidurai, A., Kukreja, R. C., & Das, A. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/6141902 · Cited by 51
Role of MicroRNAs in Type 2 Diabetes and Associated Vascular Complications
Banerjee, J., Nema, V., Dhas, Y., & Mishra, N. (2017) · Biochimie · doi:10.1016/j.biochi.2017.05.007 · Cited by 51
Metabolic Adaptations in Diabetic Endothelial Cells
de Zeeuw, P., Wong, B. W., & Carmeliet, P. (2015) · Circulation Journal · doi:10.1253/circj.cj-15-0230 · Cited by 53
Effects of IGF-1 on the Cardiovascular System
Obradovic, M. M., Zafirovic, S. S., Šoškić, S., Stanimirović, J., Trpković, A., Jevremović, D., & Isenović, E. R. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666191106091507 · Cited by 51
microRNA–200b as a Switch for Inducible Adult Angiogenesis
Sinha, M., Ghatak, S., Roy, S., & Sen, C. K. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.6065 · Cited by 50
From cellular senescence to age-associated diseases: the miRNA connection
Schraml, E., & Grillari, J. (2012) · Longevity & Healthspan · doi:10.1186/2046-2395-1-10 · Cited by 47

Authors: Wang, X., Qian, R., Zhang, W., Chen, S., Jin, H., & Hu, R.
Affiliations: Shanghai Medical College of Fudan University (CN)
ORCID: Chen, SF
Venue: Clinical and Experimental Pharmacology and Physiology
Publisher: Wiley
Published: 2009-01-27
Volume: 36
Issue: 2
Pages: 181-188
ISSN: 0305-1870 (ISSN-L)
1440-1681
DOI: 10.1111/j.1440-1681.2008.05057.x
OpenAlex: W2042150160
Cited by: 271
References: 38
Citations by year: 2026: 4 · 2025: 9 · 2024: 8 · 2023: 5 · 2022: 8 · 2021: 15 · 2020: 9 · 2019: 15 · 2018: 18 · 2017: 28 · 2016: 7 · 2015: 17 · 2014: 28 · 2013: 26 · 2012: 24
FWCI: 5.69
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Clinical and Experimental Pharmacology and Physiology (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
Keywords: type 2 diabetes, insulin-like growth factor I, IGF-1 receptor, impaired angiogenesis, Goto-Kakizaki rats, miRNA expression profiling, endothelial cell proliferation and migration, let-7e, miR-129, miR-370
MeSH terms: Animals, Cells, Cultured, Coronary Vessels, Diabetes Mellitus, Experimental, Diabetes Mellitus, Type 2, Insulin-Like Growth Factor I, Myocardium, Transfection, Up-Regulation, Rats, Wistar, Neovascularization, Physiologic, Reverse Transcriptase Polymerase Chain Reaction, MicroRNAs, Endothelial Cells, Microarray Analysis, Rats, Microvessels

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

MicroRNA‐320 EXPRESSION IN MYOCARDIAL MICROVASCULAR ENDOTHELIAL CELLS AND ITS RELATIONSHIP WITH INSULIN‐LIKE GROWTH FACTOR‐1 IN TYPE 2 DIABETIC RATS

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks